You just read:

Use of CRISPR Cas9 Gene Editing Therapeutic Shown to Permanently Inactivate HIV-1 in Patient's Blood for First Time

News provided by

Excision BioTherapeutics Inc.

Mar 21, 2016, 17:31 ET